In order to speed up the implementation of the innovation-driven development strategy and strengthen the main position of enterprise innovation, on October 29, the Henan Provincial Department of Industry and Information Technology and the Henan Provincial Department of Finance announced the list of Henan Province's technological innovation demonstration enterprises in 2021. Recognized as 47 enterprises as provincial-level technological innovation demonstration enterprises, Henan Huibo Medical Co., Ltd. was honorably selected.
Technological innovation demonstration enterprises refer to enterprises with strong technological innovation capabilities, outstanding innovation performance, and important demonstration and guiding roles in the main industries of the industry. Henan Province's technological innovation demonstration enterprises implement dynamic management, review and evaluation once every three years, confirm qualified demonstration enterprises, and revoke the title of unqualified ones. As a technological innovation demonstration enterprise in Henan Province, Huibo Medical will continue to implement, strengthen and improve the construction of the enterprise technological innovation system, insist on high-intensity research and development investment, attach importance to the training, introduction, use and management of scientific and technical personnel and high-skilled personnel, and give full play to the industry The leading and supporting role of technological innovation and product research and development of upstream and downstream enterprises in the chain, and the summary and promotion of technological innovation work methods and work experience, and contribute to the overall improvement of the technological innovation level of the industrial industry in our province.
Henan Huibo Medical Co., Ltd. was selected
At present, Huibo Group is constructing the entire industry chain of health care with a global perspective, focusing on digital health care to spread across the country. The company's annual R&D investment accounts for 10% of its annual sales revenue. It has a sound R&D institution and has established long-term and stable cooperative relations with research institutions such as Leuven University in Belgium. It attaches great importance to the training, introduction and use of scientific and technical personnel and high-skilled personnel. Huibo Medical will be guided by market demand, with the goal of returning patients to health, relying on product innovation and research and development, to continuously improve innovation capabilities, enhance core competitiveness, continue to deepen the health care industry, and take specialization, refinement, and specialization. Innovative development path.